Bhalla K - Search Results

1

Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.

George P, Bali P, Annavarapu S, Scuto A, Fiskus W, Guo F, Sigua C, Sondarva G, Moscinski L, Atadja P, Bhalla K. George P, et al. Among authors: bhalla k. Blood. 2005 Feb 15;105(4):1768-76. doi: 10.1182/blood-2004-09-3413. Epub 2004 Oct 28. Blood. 2005. PMID: 15514006 Free article.

2

Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells.

Bhalla K, Tang C, Ibrado AM, Grant S, Tourkina E, Holladay C, Hughes M, Mahoney ME, Huang Y. Bhalla K, et al. Blood. 1992 Dec 1;80(11):2883-90. Blood. 1992. PMID: 1450413 Free article.

3

High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells.

Bhalla K, Ibrado AM, Tourkina E, Tang C, Grant S, Bullock G, Huang Y, Ponnathpur V, Mahoney ME. Bhalla K, et al. Blood. 1993 Nov 15;82(10):3133-40. Blood. 1993. PMID: 8219202 Free article.

4

Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3.

Amarante-Mendes GP, Naekyung Kim C, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K. Amarante-Mendes GP, et al. Among authors: bhalla k. Blood. 1998 Mar 1;91(5):1700-5. Blood. 1998. PMID: 9473236 Free article.

5

Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L).

Perkins C, Kim CN, Fang G, Bhalla KN. Perkins C, et al. Among authors: bhalla kn. Blood. 2000 Feb 1;95(3):1014-22. Blood. 2000. PMID: 10648417 Free article.

6

CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs.

Fang G, Kim CN, Perkins CL, Ramadevi N, Winton E, Wittmann S, Bhalla KN. Fang G, et al. Among authors: bhalla kn. Blood. 2000 Sep 15;96(6):2246-53. Blood. 2000. PMID: 10979973 Free article.

7

Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells.

Wen J, Ramadevi N, Nguyen D, Perkins C, Worthington E, Bhalla K. Wen J, et al. Among authors: bhalla k. Blood. 2000 Dec 1;96(12):3900-6. Blood. 2000. PMID: 11090076 Free article.

8

Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells.

Nimmanapalli R, Porosnicu M, Nguyen D, Worthington E, O'Bryan E, Perkins C, Bhalla K. Nimmanapalli R, et al. Among authors: bhalla k. Clin Cancer Res. 2001 Feb;7(2):350-7. Clin Cancer Res. 2001. PMID: 11234890

9

Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts.

Nimmanapalli R, O'Bryan E, Bhalla K. Nimmanapalli R, et al. Among authors: bhalla k. Cancer Res. 2001 Mar 1;61(5):1799-804. Cancer Res. 2001. PMID: 11280726

10

Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Brc-Abl-positive acute leukemia cells.

Porosnicu M, Nimmanapalli R, Nguyen D, Worthington E, Perkins C, Bhalla KN. Porosnicu M, et al. Among authors: bhalla kn. Leukemia. 2001 May;15(5):772-8. doi: 10.1038/sj.leu.2402104. Leukemia. 2001. PMID: 11368438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

477 results

Search Page

Filters